Module 2 Learning Objectives

Clinical Risk Assessment

Module 2

By the end of this module, you will be able to: 

• Identify clinical and demographic risk factors that increase the probability of malignancy in patients with incidental pulmonary nodules, including tobacco use, age, occupational exposures, and underlying lung disease.
• Compare the Mayo Clinic and Brock University risk prediction models in terms of included variables, applicable nodule types, and clinical utility for guiding management decisions.
• Apply quantitative risk stratification tools and Fleischner Society guidelines to determine appropriate follow-up intervals, imaging recommendations, or referral pathways for patients with incidental pulmonary nodules.
• Evaluate the role and limitations of PET/CT imaging in refining malignancy risk assessment, including its diagnostic value across different nodule sizes, morphologies, and clinical contexts.